Cancer news

Latest news, press releases and blog posts from Cancer Research UK.

Supporters

Mixing complementary therapy with standard cancer treatment could affect survival

A new study explores the impact that mixing complementary therapy with conventional cancer treatment can have on survival.

NHS scan delays must be addressed, says health regulator

The time taken for radiology scans to be analysed and the results reported back to doctors varies widely across England, according to a new report.

Boys should be given HPV jab, says vaccine committee. Here’s what happens next.

The Joint Committee for Vaccination and Immunisation has recommended that boys are offered the HPV vaccine. We look at what this could mean and next steps.

Prescriptions for stop smoking aids have plummeted, says report

The number of GP prescriptions for stop smoking aids in England has fallen by 75% in the last decade, according to new figures.

Older people and cancer: how research could personalise treatment plans and care

We look at how research could help to adapt and improve treatment for older patients, including inclusive clinical trials and pre-habilitation.

News digest – immunotherapy for childhood cancer, glowing brain surgery, a new health secretary and CRISPR

A dye used in brain tumour surgery will be rolled out more widely and an immunotherapy drug for neuroblastoma has been made available on NHS.

Life-extending immunotherapy approved on NHS for children with neuroblastoma

Children in England with high-risk neuroblastoma will now be offered a cancer drug that could extend their life.

Brain tumour surgery dye now available to more NHS patients

A chemical dye that lights up brain tumours during surgery should be available to more NHS patients in England, according to NICE.

Exploiting the brain tumour environment to make better treatments

Brain tumours are heavily influenced by their surroundings so understanding the environment they’re in could reveal ways to destroy them.

Brain tumour chemotherapy now available to even more NHS patients

Thanks to a trial we supported, people with a type of brain tumour now have a new treatment option – a chemotherapy we developed.

Pages